• Advertise
  • Contact Us
  • Write For Us
  • Our Team
Extraction Magazine
No Result
View All Result
  • Botanical Extraction
    • Cannabinoids
    • Psychedelics
    • Nutraceutical
    • Product Refinement
  • Industry News
    • Business
    • Sustainability
    • Safety & Compliance
    • Partners
  • Extraction Technology
    • Equipment
    • Methods
    • Solvents
    • DIY Extraction
    • Analytical Techniques
  • Medical Research
  • Glossary
  • Business Directory
  • Botanical Extraction
    • Cannabinoids
    • Psychedelics
    • Nutraceutical
    • Product Refinement
  • Industry News
    • Business
    • Sustainability
    • Safety & Compliance
    • Partners
  • Extraction Technology
    • Equipment
    • Methods
    • Solvents
    • DIY Extraction
    • Analytical Techniques
  • Medical Research
  • Glossary
  • Business Directory
No Result
View All Result
Extraction Magazine
No Result
View All Result
Home Industry News

Is Big Pharma On-Board with CBD Extraction?

Nicholas Demski by Nicholas Demski
April 13, 2018
in Industry News
Is Big Pharma On-Board with CBD Extraction?

Someone recently asked me, ‘will Big Pharma become involved in extraction?’ Depending on your definition of “involved,” they already are.

Big Pharma Wants to Keep Their Pie

Let’s be clear, if it wasn’t for the status of cannabis as a Schedule I drug, Big Pharma would likely already be considerably hedged into that market.

READ ALSO

Green Extraction Techniques and Smart Solvents for Bioactive Recovery

Cannabis Business In South America

It’s exceedingly difficult to manufacture a CBD product that will be approved by the FDA; that’s why there are so few of them and why they are so expensive for Big Pharma to commercialize.

Big Pharma knows the economic value of cannabis as well as anyone; it’s estimated that if Cannabis were legalized in all 50 states, Big Pharma would lose out on at least $500 million in annual revenue as people replace their prescription pills with medical cannabis (1).

Perhaps reluctant to mitigate a reliable revenue stream, Big Pharma has looked to legislative wins to maintain the status quo. In South Dakota, for example, when SB 95 was being written to move CBD to a Schedule IV drug and remove it from the category of ‘marijuana,’ Big Pharma pushed for an amendment that specified the acceptance of only FDA-approved CBD products. As the market for CBD currently stands in states with legalization (and even some without), that would force their competitors to reach the FDA’s standards, as well.

Big Pharma’s Foot in the Door

The amendment would limit the legality only to drugs like Epidiolex, the most poignant example of Big Pharma’s cannabis extraction endeavors. Though drugs like Epidolex™ and Marinol™ are shown to be effective medicines at times, whole plant extracts from cannabis provide the healing properties of terpenes and THC, as well as CBD (2). The entourage effect simply provides better healing qualities than any categorized extract.

As patients emphasize their preference of whole-flower extracts over segregated extractions, the world has taken notice of the medicinal efficacy of CBD.

Figure 1 Whole plant extracts utilize the entourage effect, Epidiolex does not.

After the World Health Organization announced their conclusions that CBD is an effective medicine with nearly zero health risks, many were hopeful it would lead to the eventual legalization of cannabis (3). It has been, but in the same way a domino leads to the collapse of the entire domino chain. When the domino chain of prohibition eventually clinks to an end, the market for extraction is going to open in ways we can’t predict.

Given their current relationship with CBD extracts and their historical involvement in synthesizing cannabis products, it should come as no surprise that Big Pharma will launch its efforts deeper into the cannabis industry upon federal legalization.

So, the question isn’t ‘will Big Pharma become involved in extraction?’ It’s ‘what role will they play in its federally legal industry?’

Image credit: https://mmjdoctor.com/marijuana-is-not-a-gateway-drug-painkillers-are/

Related Posts

Green Extraction Techniques
Sustainability

Green Extraction Techniques and Smart Solvents for Bioactive Recovery

January 10, 2025
A vision for the cannabis business
Business

Cannabis Business In South America

September 16, 2024
Journey of Cannabis in America
Business

From Prohibition to Progress: The Oscillating Journey of Cannabis in America

September 13, 2024
Social Clubs in Spain
Business

Cannabis Social Clubs in Spain vs CoffeeShops in the Netherlands

August 23, 2024
Cannabis Industry Sector
Business

Latest News From The Cannabis Industry Sector

August 16, 2024
Cannabis in Asia
Business

Cannabis in Asia – Overview of Asian Laws

August 9, 2024
Next Post
Should I Use an Isolate or a Whole-Plant Concentrate?

Should I Use an Isolate or a Whole-Plant Concentrate?

LATEST ARTICLES

Green Extraction Techniques

Green Extraction Techniques and Smart Solvents for Bioactive Recovery

January 10, 2025
Wide angle view at two workers wearing protective suits while inspecting production at modern chemical plant, copy space

Collaborative Approaches in Botanical Extraction: Bridging Science and Industry

January 7, 2025
Areca Catechu

Inside the Betel Nut High: Exploring the Mind-Bending Effects of Areca Catechu

January 1, 2025
The Art of Extraction: Unlocking Nature’s Fragile Secrets

The Art of Extraction: Unlocking Nature’s Fragile Secrets

December 27, 2024

Subscribe Now

Subscribe to our newsletter now to receive quick updates from us



    Background
    About

    Extraction Magazine is the trusted provider of botanical extraction news, ever-changing politics, cool gadgets and technologies, and methods for producing safe, ethical, and compliant formulations.

    Advertisers
    Navigation
    • Botanical Extraction
    • Industry News
    • Extraction Technology
    • Medical Research
    • Glossary
    • Business Directory
    Recent Posts
    • Green Extraction Techniques and Smart Solvents for Bioactive Recovery
    • Collaborative Approaches in Botanical Extraction: Bridging Science and Industry
    • Inside the Betel Nut High: Exploring the Mind-Bending Effects of Areca Catechu
    • The Art of Extraction: Unlocking Nature’s Fragile Secrets
    Subscribe to our Newsletter
    loader

    Sitemap

    © 2025 Extraction Magazine is the trusted provider of botanical extraction news and the leading media in the ever-changing extraction industry.

    No Result
    View All Result
    • Industry News
    • Botanical Extraction
    • Medical Research
    • Medical Research
    • Glossary
    • Our Team
    • Write For Us

    © 2023 Extraction Magazine is the trusted provider of botanical extraction news and the leading media in the ever-changing extraction industry.